Page last updated: 2024-12-11

cinnamylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6008559
SCHEMBL ID1872
MeSH IDM0163241

Synonyms (29)

Synonym
cinnamylamine
3-phenylprop-2-en-1-amine
RDAFNSMYPSHCBK-QPJJXVBHSA-N
4360-51-4
(2e)-3-phenyl-2-propen-1-amine
(e)-3-phenylprop-2-en-1-amine
EN300-75742
4335-60-8
AKOS005175005
3-phenyl-2-propen-1-amine
unii-7360f8ga70
2-propen-1-amine, 3-phenyl-
7360f8ga70 ,
3-amino-1-phenylprop-1-ene
cyclopropanamine, 2-phenyl-, hydrochloride, (1r,2r)-rel-2-propen-1-amine, 3-phenyl-, (2e)-
(2e)-3-phenyl-2-propenylamine
trans-cinnamylamine
trans-3-phenyl-2-propenylamine
kru5188qar ,
cinnamylamine, (e)-
(e)-3-phenylallylamine
(e)-cinnamylamine
unii-kru5188qar
SCHEMBL1872
AS-60263
(2e)-3-phenylprop-2-en-1-amine
mfcd00062777
Q27282399
EN300-717557

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.57 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]